The following corporate finance-related stories were reported by media on Wednesday:* Pfizer Inc plans to cut about 20 percent of its sales force for primary-care drugs, Bloomberg News reported, as the pharmaceutical company copes with the loss of a patent for top-selling cholesterol drug Lipitor.
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. Shares of PFE traded higher by 1.12% or $0.285/share to $25.64. In the past year, the shares have traded as low as $20.75 and as high as $26.09. On average, 29589700 shares of PFE exchange hands on a given day and today's volume is recorded at 33083324.
Source
